A case report of nephrotic syndrome due to collapsing focal segmental glomerulosclerosis treated with low-density lipoprotein apheresis

被引：8

作者：

Miyazono, Motoaki ^{[1
]}

Tomiyoshi, Yoshiyuki ^{[2
]}

Kishi, Tomoya ^{[1
]}

Ikeda, Yuji ^{[1
]}

Sakemi, Takanobu ^{[1
]}

Sanai, Toru ^{[1
]}

Node, Koichi ^{[1
]}

机构：

[1] Saga Univ, Dept Internal Med, Fac Med, Saga 8498501, Japan

[2] Saga Prefectural Hosp, Dept Renal Med, Saga, Japan

来源：

THERAPEUTIC APHERESIS AND DIALYSIS | 2008年 / 12卷 / 04期

关键词：

collapsing focal segmental glomerulosclerosis; low-density lipoprotein apheresis; nephrotic syndrome;

D O I：

10.1111/j.1744-9987.2008.00596.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We herein report the case of a 73-year-old woman with steroid and cyclosporine resistant collapsing focal segmental glomerulosclerosis (FSGS) whose refractory proteinuria and hypoproteinemia were controlled with low-density lipoprotein apheresis (LDL-A). She was initially treated with steroid therapy, including methylprednisolone pulse and cyclosporine therapy. However, her hypoproteinemia, accompanied with renal insufficiency, persisted despite these therapies. We treated her using LDL-A and found improvement in her urine protein excretion, hyperlipidemia, hypoproteinemia, and renal function as a result of this treatment. This suggests that LDL-A may therefore be an effective therapy for nephrotic syndrome due to collapsing FSGS.

引用

页码：333 / 336

页数：4

共 50 条

[31] CASE REPORT: Collapsing Focal Segmental Glomerulosclerosis with Recovery of Renal Function
David F. Stein
Abdurhman Ahmed
Vijaya Sunkhara
Walid Khalbuss
Digestive Diseases and Sciences, 2001, 46 (3) : 530 - 535
[32] MesalazineFocal segmental glomerulosclerosis and nephrotic syndrome: case report
Reactions Weekly, 2021, 1853 (1) : 290 - 290
[33] DasatinibFocal segmental glomerulosclerosis and nephrotic syndrome : case report
Reactions Weekly, 2021, 1849 (1) : 161 - 161
[34] DasatinibFocal segmental glomerulosclerosis and nephrotic syndrome: case report
Reactions Weekly, 2021, 1837 (1) : 200 - 200
[35] Umbilical Cord Blood Transplantation-associated Nephrotic Syndrome Successfully Treated by Low-density Lipoprotein Apheresis
Sugawara, Yuka
Honda, Kenjiro
Katagiri, Daisuke
Nakamura, Motonobu
Kawakami, Takahisa
Nasu, Ryo
Hayashi, Akimasa
Shintani, Yukako
Tojo, Akihiro
Noiri, Eisei
Kurokawa, Mineo
Fukayama, Masashi
Nangaku, Masaomi
INTERNAL MEDICINE, 2016, 55 (19) : 2831 - 2836
[36] UstekinumabFocal segmental glomerulosclerosis and nephrotic syndrome: case report
Reactions Weekly, 2019, 1745 (1) : 262 - 262
[37] IMPACT OF LOW-DENSITY LIPOPROTEIN APHERESIS FOR NEPHROTIC SYNDROME IN A PATIENT WITH IMMUNOGLOBULIN M NEPHROPATHY
Tanaka, Atsushi
Nakamura, Tsukasa
Sato, Eiichi
Node, Koichi
NEPHROLOGY, 2016, 21 (12) : 1073 - 1074
[38] Evaluation of efficacy of low-density lipoprotein apheresis to improve diabetic nephrotic syndrome.
Yunoki, O
Yasumoto, Y
Miyashita, H
Homan, H
Haruta, T
Ueda, T
Uchida, Y
Yoshidome, E
Ikeda, T
Arima, T
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A0607 - A0607
[39] Low-density Lipoprotein Receptor Activities, Lipids, Apolipoprotein, and Clinical Course of Patients with Steroid-resistant Nephrotic Syndrome Treated with Low density Lipoprotein Apheresis: A Case Series
Shima, Hisato
Higashiguchi, Yusuke
Doi, Toshio
Harada, Megumi
Okamoto, Takuya
Inoue, Tomoko
Tashiro, Manabu
Okada, Kazuyoshi
Minakuchi, Jun
INTERNAL MEDICINE, 2024, 63 (03) : 433 - 438
[40] LOW-DENSITY LIPOPROTEIN METABOLISM IN THE NEPHROTIC SYNDROME
WARWICK, GL
CASLAKE, MJ
BOULTONJONES, JM
DAGEN, M
PACKARD, CJ
SHEPHERD, J
METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (02): : 187 - 192

← 1 2 3 4 5 →